Vertex Pharmaceuticals (VRTX) Net Income Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 60.27% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.80% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -3.84% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 19.97% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 47.10% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.80% |
| Dec 31, 2025 | 13.30% |
| Sep 30, 2025 | 5.19% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | -5.35% |
| Dec 31, 2024 | 5.84% |
| Sep 30, 2024 | 7.06% |
| Jun 30, 2024 | -281.76% |
| Mar 31, 2024 | 18.96% |
| Dec 31, 2023 | 17.05% |
| Sep 30, 2023 | 15.76% |
| Jun 30, 2023 | 3.03% |
| Mar 31, 2023 | 5.10% |
| Dec 31, 2022 | 11.98% |
| Sep 30, 2022 | 152.91% |
| Jun 30, 2022 | 44.72% |
| Mar 31, 2022 | 41.56% |
| Dec 31, 2021 | -20.37% |
| Sep 30, 2021 | 87.88% |
| Jun 30, 2021 | -31.26% |
| Mar 31, 2021 | 42.17% |
| Dec 31, 2020 | 80.83% |
| Sep 30, 2020 | 62.54% |
| Jun 30, 2020 | 199.49% |
| Mar 31, 2020 | 34.17% |
| Dec 31, 2019 | 175.94% |
| Sep 30, 2019 | 51.17% |
| Jun 30, 2019 | 111.03% |
| Mar 31, 2019 | 111.35% |
| Dec 31, 2017 | 688.87% |
| Sep 30, 2017 | -1,556.62% |
| Jun 30, 2017 | 376.78% |
| Mar 31, 2017 | 797.62% |
| Dec 31, 2016 | 29.46% |
| Sep 30, 2016 | -76.37% |
| Jun 30, 2016 | -134.21% |